<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?DTDIdentifier.IdentifierValue article.dtd?>
  <?DTDIdentifier.IdentifierType system?>
  <?SourceDTD.DTDName article.dtd?>
  <?SourceDTD.Version 1.0?>
  <?ConverterInfo.XSLTName bmc2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Neurodegener</journal-id>
      <journal-title-group>
        <journal-title>Molecular Neurodegeneration</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1750-1326</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3113299</article-id>
      <article-id pub-id-type="publisher-id">1750-1326-6-30</article-id>
      <article-id pub-id-type="pmid">21554715</article-id>
      <article-id pub-id-type="doi">10.1186/1750-1326-6-30</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Similarities and differences in structure, expression, and functions of VLDLR and ApoER2</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Reddy</surname>
            <given-names>Sunil S</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>ssr24@hoyamail.georgetown.edu</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Connor</surname>
            <given-names>Teal E</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>tc297@hoyamail.georgetown.edu</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Weeber</surname>
            <given-names>Edwin J</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>eweeber@health.usf.edu</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A4">
          <name>
            <surname>Rebeck</surname>
            <given-names>William</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>gwr2@georgetown.edu</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Biology; Georgetown University, 37th and O Streets, NW, Washington, DC, 20057, USA</aff>
      <aff id="I2"><label>2</label>Department of Neuroscience; Georgetown University Medical Center, 3970 Reservoir Rd, NW, Washington, DC, 20007, USA</aff>
      <aff id="I3"><label>3</label>Department of Molecular Pharmacology &amp; Physiology; University of South Florida, 4001 E. Fletcher Ave., Tampa, FL, 33612-4742, USA</aff>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>9</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <volume>6</volume>
      <fpage>30</fpage>
      <lpage>30</lpage>
      <history>
        <date date-type="received">
          <day>19</day>
          <month>1</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>5</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2011 Reddy et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Reddy et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.molecularneurodegeneration.com/content/6/1/30"/>
      <abstract>
        <p>Very Low Density Lipoprotein Receptor (VLDLR) and Apolipoprotein E Receptor 2 (ApoER2) are important receptors in the brain for mediating the signaling effects of the extracellular matrix protein Reelin, affecting neuronal function in development and in the adult brain. VLDLR and ApoER2 are members of the low density lipoprotein family, which also mediates the effects of numerous other extracellular ligands, including apolipoprotein E. Although VLDLR and ApoER2 are highly homologous, they differ in a number of ways, including structural differences, expression patterns, alternative splicing, and binding of extracellular and intracellular proteins. This review aims to summarize important aspects of VLDLR and ApoER2 that may account for interesting recent findings that highlight the unique functions of each receptor.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Very Low Density Lipoprotein Receptor (VLDLR) and Apolipoprotein E Receptor 2 (ApoER2; also known as LRP8) are members of the LDL receptor family, a group associated with cellular cholesterol homeostasis [<xref ref-type="bibr" rid="B1">1</xref>]. LDL receptor family members are type I transmembrane receptors and have five highly conserved structural domains: an extracellular N-terminal ligand-binding domain with cysteine-rich repeats, an epidermal growth factor (EGF) domain, an O-linked sugar domain, a single transmembrane sequence, and a cytoplasmic domain containing an NPxY motif. The overall sequence homology between VLDLR and ApoER2 is around 50% [<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>VLDLR and ApoER2 are primarily recognized for their role in neural development through Reelin signaling, a process that is responsible for proper positioning of newly generated neurons leading to the inside-out formation of the six-layered neocortex [<xref ref-type="bibr" rid="B3">3</xref>]. Reelin is a glycoprotein secreted by Cajal-Retzius cells that signals neurons to migrate radially past earlier-generated cells to arrive at the appropriate lamina [<xref ref-type="bibr" rid="B4">4</xref>]. Reelin signaling is also important for alignment of pyramidal neurons in the hippocampus and Purkinje cells of the cerebellum [<xref ref-type="bibr" rid="B3">3</xref>]. In this pathway, VLDLR and ApoER2 are cell surface receptors for Reelin [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Interaction with Reelin induces VLDLR and ApoER2 to bind the adaptor protein Dab1 at an NPxY motif on their cytoplasmic tails [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Binding of Dab1 subsequently leads to activation of Src family tyrosine kinases (SFKs) and other kinases that phosphorylate the adaptor protein at its tyrosine residues [<xref ref-type="bibr" rid="B9">9</xref>]. VLDLR and ApoER2 are the exclusive Reelin signaling receptors, and, consistent with their high extracellular sequence homology, bind Reelin with similar affinities [<xref ref-type="bibr" rid="B10">10</xref>]. Mutations or deletions of the <italic>Reelin </italic>gene, the <italic>Dab1 </italic>gene, or the genes for both <italic>VLDLR </italic>and <italic>ApoER2 </italic>result in improper neuronal migration, cortical laminating defects, and cerebellar hypoplasia [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>].</p>
      <p>Secreted Reelin can form complexes, including homodimers, which allows association and clustering of multiple receptors simultaneously [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. This receptor clustering is necessary for the phosphorylation of Dab1 and its subsequent interaction with kinases [<xref ref-type="bibr" rid="B9">9</xref>]. Ligand binding to VLDLR and ApoER2 also initiates clathrin-dependent receptor endocytosis, which likely modulates further ligand signaling [<xref ref-type="bibr" rid="B14">14</xref>]. Dab1 phosphorylation following Reelin activation of apoE receptors leads to Dab1 degradation by proteosomes [<xref ref-type="bibr" rid="B15">15</xref>]. Thus, there are several mechanisms for regulating the Reelin signaling mechanisms.</p>
      <p>Studies of the developing CNS suggest that VLDLR and ApoER2 serve overlapping functions in controlling neuronal migration. However, several recent studies have demonstrated clear differences in VLDLR and ApoER2 splicing, localization, interactors, and trafficking. The differences in receptor function during development also translate into differences in adult brain function. Both VLDLR and ApoER2 are receptors for apolipoprotein E (apoE), the leading genetic risk factor for Alzheimer's disease (AD) [<xref ref-type="bibr" rid="B16">16</xref>], and these receptors may play different roles in modulating the risk associated with apoE. Here, we explore VLDLR, ApoER2, and importantly, the distinctions between them.</p>
      <sec>
        <title>Comparison of VLDLR and ApoER2 proteins</title>
        <sec>
          <title>Structure</title>
          <p>Full length human <italic>VLDLR </italic>mRNA encodes a protein of 873 amino acids ([<xref ref-type="bibr" rid="B17">17</xref>]; NCBI Accession NM_003383.3). VLDLR has eight cysteine-rich ligand-binding repeats (LBRs) of approximately 40 amino acids each, an EGF region with three cysteine rich repeats, a 46 amino acid O-linked glycosylation domain with numerous threonine and serine residues, a 22 amino acid transmembrane domain, and a 54 amino acid cytoplasmic domain containing the NPxY motif (Figure <xref ref-type="fig" rid="F1">1</xref>) [<xref ref-type="bibr" rid="B18">18</xref>]. The first 27 amino acids of the N-terminal are hydrophobic and serve as the signal peptide. A glycine residue is believed to constitute the N-terminus of the mature receptor. There is 97% amino acid identity between VLDLR in mouse and human [<xref ref-type="bibr" rid="B17">17</xref>].</p>
          <fig id="F1" position="float">
            <label>Figure 1</label>
            <caption>
              <p><bold>VLDLR and ApoER2 receptors</bold>. Specific domains are defined by vertical lines, alternative splice forms are shown with protruding "v"s, exon numbers are noted, and amino acid %-sequence identities of individual domains are indicated.</p>
            </caption>
            <graphic xlink:href="1750-1326-6-30-1"/>
          </fig>
          <p>The full length human <italic>ApoER2 </italic>mRNA encodes a protein of 870 amino acid residues (NCBI Accession NM_004631.3). ApoER2 has the same overall domain structure as VLDLR, with several important differences. ApoER2 contains a ligand-binding domain of eight LBRs (only five LBRS are ever observed in the cDNA due to splicing out of LBRs 4-6; see Figure <xref ref-type="fig" rid="F1">1</xref>), an EGF domain with three cysteine-rich repeats, an O-linked glycosylation domain of 89 amino acids, a transmembrane domain of 24 amino acids, and a cytoplasmic domain of 115 amino acids (Figure <xref ref-type="fig" rid="F1">1</xref>) [<xref ref-type="bibr" rid="B2">2</xref>]. The signal peptide consists of approximately 40 amino acids. Homology between ApoER2 in mouse and human is approximately 90%. In humans, VLDLR and ApoER2 share a roughly 50% primary sequence homology, with the O-linked glycosylation domain (21%) and transmembrane domain (35%) being the least identical [<xref ref-type="bibr" rid="B2">2</xref>].</p>
          <p>Thus, the gene sequences of <italic>VLDLR </italic>and <italic>ApoER2 </italic>differ most dramatically in their O-linked glycosylation domains; this domain in ApoER2 is more than twice the size of that in VLDLR.</p>
        </sec>
        <sec>
          <title>Distribution (Temporal and Spatial)</title>
          <p><italic>VLDLR </italic>mRNA transcripts are most abundant in brain with high expression in the heart and skeletal muscle as well (Table <xref ref-type="table" rid="T1">1</xref>). These tissues have relatively high levels of free lipids, supporting a role of VLDLR in metabolism of cholesterol and fatty acids [<xref ref-type="bibr" rid="B18">18</xref>]. Within the adult brain, <italic>VLDLR </italic>mRNA is found in nearly all regions, with highest expression in the cortex and cerebellum (Table <xref ref-type="table" rid="T2">2</xref>). Within these regions, VLDLR is found on microglia and region-specific pyramidal neurons [<xref ref-type="bibr" rid="B19">19</xref>], as well as in neuroblasts, matrix cells, Cajal-Retzius cells, glioblasts, astrocytes, and oligodendrocytes [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>] (Table <xref ref-type="table" rid="T3">3</xref>). Subcellularly, VLDLR is in non-lipid raft fractions of cell membranes [<xref ref-type="bibr" rid="B14">14</xref>].</p>
          <table-wrap id="T1" position="float">
            <label>Table 1</label>
            <caption>
              <p>Expression of VLDLR and ApoER2 in mouse organs. +/-, +, and ++ represent increasing levels of expression [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B18">18</xref>].</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th/>
                  <th align="center">Brain</th>
                  <th align="center">Heart</th>
                  <th align="center">Testis</th>
                  <th align="center">Ovary</th>
                  <th align="center">Kidney</th>
                  <th align="center">Muscle</th>
                  <th align="center">Placenta</th>
                  <th align="center">Lung</th>
                  <th align="center">Adipose Tissue</th>
                  <th align="center">Small Intestine</th>
                  <th align="center">Liver</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center">VLDLR</td>
                  <td align="center">++</td>
                  <td align="center">++</td>
                  <td align="center">+</td>
                  <td align="center">+</td>
                  <td align="center">++</td>
                  <td align="center">++</td>
                  <td align="center">-</td>
                  <td align="center">+</td>
                  <td align="center">+</td>
                  <td align="center">+/-</td>
                  <td align="center">+/-</td>
                </tr>
                <tr>
                  <td colspan="12">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">ApoER2</td>
                  <td align="center">++</td>
                  <td align="center">-</td>
                  <td align="center">++</td>
                  <td align="center">+/-</td>
                  <td align="center">-</td>
                  <td align="center">-</td>
                  <td align="center">+</td>
                  <td align="center">-</td>
                  <td align="center">-</td>
                  <td align="center">-</td>
                  <td align="center">-</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <table-wrap id="T2" position="float">
            <label>Table 2</label>
            <caption>
              <p>Regional expression of VLDLR and ApoER2 within adult mouse brain.</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th align="center">Brain:</th>
                  <th align="center">TH</th>
                  <th align="center">CX</th>
                  <th align="center">ST</th>
                  <th align="center">HI</th>
                  <th align="center">HY</th>
                  <th align="center">CB</th>
                  <th align="center">BR</th>
                  <th align="center">OB</th>
                  <th align="center">SE</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center">VLDLR</td>
                  <td align="center">+</td>
                  <td align="center">+</td>
                  <td align="center">+</td>
                  <td align="center">+</td>
                  <td align="center">+</td>
                  <td align="center">+</td>
                  <td align="center">+</td>
                  <td align="center">-</td>
                  <td align="center">+</td>
                </tr>
                <tr>
                  <td colspan="10">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">ApoER2</td>
                  <td align="center">-</td>
                  <td align="center">+</td>
                  <td align="center">-</td>
                  <td align="center">+</td>
                  <td align="center">-</td>
                  <td align="center">+</td>
                  <td align="center">-</td>
                  <td align="center">+</td>
                  <td align="center">-</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <p>TH = Thalamus, CX = Cerebral Cortex, ST = Striatum, HI = Hippocampus, HY = Hypothalamus, CB = Cerebellum, BR = Brainstem, OB = Olfactory bulb, SE = Septum [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B18">18</xref>].</p>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap id="T3" position="float">
            <label>Table 3</label>
            <caption>
              <p>Cellular expression of VLDLR and ApoER2 within mouse brain [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B21">21</xref>].</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th/>
                  <th align="center">Glia</th>
                  <th align="center">Cortical Plate Neurons</th>
                  <th align="center">Hippocampal Pyramidal Neurons</th>
                  <th align="center">Cajal-Retzius cells</th>
                  <th align="center">Olfactory Mitral Cells</th>
                  <th align="center">Cerebellar Purkinje Cells</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center">VLDLR</td>
                  <td align="center">+</td>
                  <td align="center">++</td>
                  <td align="center">+</td>
                  <td align="center">++</td>
                  <td align="center">-</td>
                  <td align="center">+</td>
                </tr>
                <tr>
                  <td colspan="7">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">ApoER2</td>
                  <td align="center">-</td>
                  <td align="center">++</td>
                  <td align="center">+</td>
                  <td align="center">-</td>
                  <td align="center">++</td>
                  <td align="center">++</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p><italic>ApoER2 </italic>mRNA is present exclusively in CNS, placenta, and testis [<xref ref-type="bibr" rid="B2">2</xref>] (Table <xref ref-type="table" rid="T1">1</xref>). Immunohistochemical analysis reveals ApoER2 expression in the hippocampus, cerebellum, mitral cell layer of the olfactory bulb, neocortex (cell bodies and dendrites), and cortical neurons [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>] (Table <xref ref-type="table" rid="T2">2</xref>). In the hippocampus, ApoER2 is found in granule cells of the dentate gyrus and pyramidal cells of all CA subfields [<xref ref-type="bibr" rid="B21">21</xref>]. In the cerebellum, ApoER2 is found densely in Purkinje cells [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B21">21</xref>] (Table <xref ref-type="table" rid="T3">3</xref>). Subcellularly, ApoER2 is differentially sorted into lipid raft fractions of cell membranes [<xref ref-type="bibr" rid="B14">14</xref>].</p>
          <p><italic>VLDLR </italic>and <italic>ApoER2 </italic>also have different patterns of tissue expression over development (Table <xref ref-type="table" rid="T4">4</xref>). At E12 of development both <italic>VLDLR </italic>and <italic>ApoER2 </italic>are expressed at low levels in the preplate. From E12.5-E13.5, <italic>ApoER2 </italic>is expressed in the inner and middle locations of the cortex; and at E15, <italic>ApoER2 </italic>is in the olfactory bulb and in medial cortical fields. At E15, <italic>VLDLR </italic>is seen in the hippocampal anlage-medial cortex, paleocortex, subplate of the upper cortical plate, and weakly in the neocortical plate and Cajal-Retzius cells. From E16.5-E17 <italic>ApoER2 </italic>expression is in the outermost cortex as well as deeper cerebellar layers, and at E18, <italic>ApoER2 </italic>is expressed in the same regions as VLDLR was at E15, with the exception of Cajal-Retzius cells. <italic>VLDLR </italic>at E18 maintains the same as its E15 expression pattern but with stronger expression in Cajal-Retzius cells, and signal in Purkinje cells. Postnatally, from P0-P6, both <italic>VLDLR </italic>and <italic>ApoER2 </italic>are expressed in the subplate and pyramidal cells of layers III and V; <italic>VLDLR </italic>is additionally in Cajal-Retzius and Purkinje cells postnatally [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. Thus, <italic>VLDLR </italic>is expressed earlier in development and is more highly expressed in Cajal-Retzius cells than <italic>ApoER2</italic>.</p>
          <table-wrap id="T4" position="float">
            <label>Table 4</label>
            <caption>
              <p>Temporal and spatial expression of <italic>VLDLR </italic>and <italic>ApoER2 </italic>within developing embryonic mouse brain [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>].</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th align="center">Developmental day</th>
                  <th align="center">E12</th>
                  <th align="center">E12.5-13.5</th>
                  <th align="center">E15-E15.5</th>
                  <th align="center">E16.5-E17</th>
                  <th align="center">E18</th>
                  <th align="center">P0-P6</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center">VLDLR</td>
                  <td align="center">Low expression in preplate</td>
                  <td align="center">Intermediate zone and cortical plate</td>
                  <td align="center">Developing hippocampus; palaeocortex; neocortical plate; Cajal-Retzius cells; subplate; deep layers of cerebellum</td>
                  <td align="center">All areas as E15</td>
                  <td align="center">All areas as E15, plus: Stronger expression in Cajal-Retzius cells; Purkinje cells</td>
                  <td align="center">Subplate and pyramidal cells of layers III and V; Cajal-Retzius cells; Purkinje cells</td>
                </tr>
                <tr>
                  <td colspan="7">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">ApoER2</td>
                  <td align="center">Low expression in preplate</td>
                  <td align="center">Inner and middle locations of cortex</td>
                  <td align="center">Medial cortical fields; olfactory bulb; ubiquitously in cerebellum</td>
                  <td align="center">Outermost cortex; deeper cerebellar layers</td>
                  <td align="center">Developing hippocampus; palaeocortex; neocortical plate, subplate</td>
                  <td align="center">Subplate and pyramidal cells of layers III and V</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </sec>
        <sec>
          <title>Splicing</title>
          <p>Both <italic>VLDLR </italic>and <italic>ApoER2 </italic>undergo alternative splicing to produce several transcript variants. Four transcripts of <italic>VLDLR </italic>(I-IV) have been defined [<xref ref-type="bibr" rid="B20">20</xref>]. <italic>VLDLR</italic>-I, lacks none of the exons, <italic>VLDLR</italic>-II lacks exon 16 encoding the O-linked sugar domain, <italic>VLDLR</italic>-III lacks exon 4 encoding the third ligand-binding repeat, and <italic>VLDLR</italic>-IV lacks both exons 4 and 16. In adult mouse brain, over half (75%) of transcripts lack exon 16 and the next most common form lacks both exons 4 and 16. Thus, most of the VLDLR present in the brain lacks the O-linked sugar domain and thus would not be expected to be glycosylated. Astrocytes exhibit less splicing of exon 4 and exon 16 than neurons [<xref ref-type="bibr" rid="B20">20</xref>]. <italic>VLDLR </italic>containing exon 16 is increased in normal aging and Alzheimer's disease [<xref ref-type="bibr" rid="B24">24</xref>].</p>
          <p><italic>ApoER2 </italic>displays a more complex splicing pattern. Exon 5 (Figure <xref ref-type="fig" rid="F1">1</xref>), containing ligand-binding repeats 4-6, is spliced out of all transcripts [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. The eighth LBR is spliced out during very early stages of development (E12 in mouse). Some transcripts in brain and all transcripts in placenta contain a 13 amino acid insert containing a furin cleavage site in place of ligand binding repeat 8 (exon 7) [<xref ref-type="bibr" rid="B25">25</xref>]. Exon 9, encoding an EGF repeat, and exon 16, containing the O-linked sugar domain, can be alternately spliced out [<xref ref-type="bibr" rid="B21">21</xref>], resulting in a smaller, differentially glycosylated precursor form found in the ER [<xref ref-type="bibr" rid="B26">26</xref>]. Splicing of the ligand-binding and EGF repeats alters binding affinity to ligands, suggesting the different transcripts may function in fine-tuning receptor-ligand interactions [<xref ref-type="bibr" rid="B27">27</xref>]. Finally, <italic>ApoER2 </italic>contains an alternatively spliced exon (19) that encodes a 59 amino acid domain in the cytoplasmic tail [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. The exon 19 domain is proline-rich and ends 10 amino acids before the C-terminus of ApoER2. The presence of this domain promotes interactions of ApoER2 with the c-jun N-terminal kinase (JNK) interacting proteins, JIP1 and JIP2, and the synaptic protein, PSD-95 [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>] (see below).</p>
          <p>Thus, differential splicing of ApoER2 and VLDLR produce proteins with different numbers of LBRs and very different cytoplasmic domains.</p>
        </sec>
        <sec>
          <title>Interacting proteins</title>
          <p>VLDLR and ApoER2 interact with a similar, but not identical, number of proteins [<xref ref-type="bibr" rid="B30">30</xref>]. Extracellularly, these receptors mediate the effects of specific ligands. Intracellularly, protein interactions alter receptor trafficking and processing [<xref ref-type="bibr" rid="B31">31</xref>]. In addition, proteolytic enzymes act on the receptors to generate N- and C-terminal fragments [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. We summarize some of these interacting proteins below (see also Table <xref ref-type="table" rid="T5">5</xref> and Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
          <table-wrap id="T5" position="float">
            <label>Table 5</label>
            <caption>
              <p>Interactions of various molecules with VLDLR and ApoER2.</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th align="center">VLDLR</th>
                  <th/>
                  <th align="center">Ectodomain Interactor</th>
                  <th/>
                  <th align="center">ApoER2</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="center">unknown</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">Reelin</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">LBR1</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">LBR</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">Thrombospondin F-spondin</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">LBR</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">LBR 5-8</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">ApoE</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">LBR 1-3, 7</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td/>
                  <td align="center">-</td>
                  <td align="center">selenoprotein</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">unknown</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td/>
                  <td/>
                  <td/>
                  <td/>
                  <td/>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">
                    <bold>VLDLR</bold>
                  </td>
                  <td/>
                  <td align="center">
                    <bold>Transmembrane Interactor</bold>
                  </td>
                  <td/>
                  <td align="center">
                    <bold>ApoER2</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">Releases intracellular domains</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">&#x3B3;-secretase</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">Releases intracellular domains</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">Releases extracellular domains</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">&#x3B1;-secretase</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">Releases extracellular domains</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td/>
                  <td/>
                  <td/>
                  <td/>
                  <td/>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">
                    <bold>VLDLR</bold>
                  </td>
                  <td/>
                  <td align="center">
                    <bold>Cytoplasmic Interactor</bold>
                  </td>
                  <td/>
                  <td align="center">
                    <bold>ApoER2</bold>
                  </td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">PTB domain binds 14-residue peptide around the NPxY</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">Dab1</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">PTB domain binds 14-residue peptide around the NPxY</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td/>
                  <td align="center">-</td>
                  <td align="center">Dab2</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">PTB domain binds NPxY of ApoER2</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">NPxY followed by leucine</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">Pafah1b2 &amp; Pafah1b3</td>
                  <td align="center">-</td>
                  <td align="center">NPxY followed by arginine</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td/>
                  <td align="center">-</td>
                  <td align="center">JIP-1, JIP-2</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">Exon 19</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td/>
                  <td align="center">-</td>
                  <td align="center">PSD-95</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">Exon 19</td>
                </tr>
                <tr>
                  <td colspan="5">
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td align="center">NPxY</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">FE65</td>
                  <td align="center">
                    <bold>+</bold>
                  </td>
                  <td align="center">NPxY</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <fig id="F2" position="float">
            <label>Figure 2</label>
            <caption>
              <p><bold>VLDLR and ApoER2 interacting proteins</bold>. Some of the extracellular and intracellular proteins that interact with VLDLR and ApoER2 are indicated.</p>
            </caption>
            <graphic xlink:href="1750-1326-6-30-2"/>
          </fig>
          <sec>
            <title>Extracellular</title>
            <p><underline>Reelin</underline> is a large extracellular matrix protein (~400 kDa) expressed by Cajal-Retzius cells during embryonic development and by interneurons in the postnatal brain [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Reelin can bind to both VLDLR and ApoER2 in the absence of a co-receptor [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B34">34</xref>], although a co-receptor may be needed for efficient binding [<xref ref-type="bibr" rid="B35">35</xref>]. Reelin binds to the first ligand binding repeat of VLDLR and ApoER2; this interaction depends on a specific lysine residue in Reelin (amino acid 2467) [<xref ref-type="bibr" rid="B36">36</xref>]. Reelin is cleaved at numerous sites to generate a series of fragments [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. Reelin fragments bind equally to both VLDLR and ApoER2, but native full-length Reelin binds with higher affinity to ApoER2 (LBRs-12378) than to VLDLR [<xref ref-type="bibr" rid="B38">38</xref>]. Reelin fragments with cleaved C-terminal regions bind VLDLR and ApoER2 with a significantly higher affinity than full-length Reelin [<xref ref-type="bibr" rid="B27">27</xref>].</p>
            <p><underline>Apolipoprotein E</underline> (apoE) is a component of lipoproteins involved in phospholipid and cholesterol homeostasis [<xref ref-type="bibr" rid="B39">39</xref>]. VLDLR binds and internalizes all human isoforms of apoE (E2, E3, E4) with high affinity, including lipid-free forms, and it does so through LBRs 5-8 [<xref ref-type="bibr" rid="B39">39</xref>]. The ApoER2 LBRs binds apoE containing &#x3B2;-VLDL with high affinity, specifically the ApoER2 splice variants that lack LBR's 4-6 and LBR 8 [<xref ref-type="bibr" rid="B25">25</xref>]. ApoE bound to receptors may be internalized and degraded, recycled to the cell surface, or remain intracellular for extended periods [<xref ref-type="bibr" rid="B40">40</xref>]. ApoE leads to the cleavage of both VLDLR and ApoER2 to generate secreted forms of these receptors [<xref ref-type="bibr" rid="B33">33</xref>].</p>
            <p><underline>Thrombospondin</underline> and <underline>F-spondin</underline> are extracellular matrix proteins. Thrombospondins are a family of trimeric or pentameric proteins that are involved in cell-cell and cell-matrix communication, and affect processes such as neurite outgrowth, neuronal migration, and synaptogenesis [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>]. Thrombospondin-1 binds to the ligand binding repeats of VLDLR and ApoER2, and competes with Reelin binding [<xref ref-type="bibr" rid="B43">43</xref>]. Like Reelin, Thrombospondin can induce Dab1 phosphorylation although not the subsequent Dab1 degradation [<xref ref-type="bibr" rid="B43">43</xref>]. F-spondin is a secreted molecule whose C-terminal domain is similar to repeats found in Thrombospondin; its N-terminal domain is homologous to a domain in Reelin that promotes dimerization [<xref ref-type="bibr" rid="B44">44</xref>]. The thrombospondin domain of F-spondin interacts with the LBR domain of ApoER2 [<xref ref-type="bibr" rid="B45">45</xref>] and may bind to both VLDLR and ApoER2 in the rostral migratory stream [<xref ref-type="bibr" rid="B46">46</xref>]. Like Reelin and Thrombospondin, F-spondin can induce activation of Dab1 [<xref ref-type="bibr" rid="B47">47</xref>].</p>
            <p><underline>Selenium</underline> is a ligand for ApoER2 through its transporter, Selenoprotein P (Sepp1). Sepp1 transports selenium from the liver to other target tissues such as the testis and brain [<xref ref-type="bibr" rid="B48">48</xref>]. ApoER2 knockout mice have phenotypic similarities to Sepp1 knockout mice such as lower selenium levels in areas where ApoER2 is normally expressed (the brain and the testis) [<xref ref-type="bibr" rid="B49">49</xref>]. When fed a selenium deficient diet, ApoER2 knockouts had neurological problems, progressive neurodegeneration, and shortened survival, similar to Sepp1 knockouts on the same diet [<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B50">50</xref>]. ApoER2 mediates the endocytosis of Sepp1 [<xref ref-type="bibr" rid="B48">48</xref>].</p>
          </sec>
          <sec>
            <title>Membrane Spanning Domain</title>
            <p><underline>Secretases</underline> promote cleavage of VLDLR and ApoER2 [<xref ref-type="bibr" rid="B32">32</xref>], and these proteolytic events can be induced by ligand binding [<xref ref-type="bibr" rid="B33">33</xref>]. A soluble extracellular fragment is generated by metalloproteinase activity; cleavage of ApoER2 occurs at small levels even when unstimulated, but after Reelin stimulation cleavage significantly increases [<xref ref-type="bibr" rid="B33">33</xref>]. &#x3B3;-secretase cleaves in the intramembrane regions to generate soluble intracellular domains [<xref ref-type="bibr" rid="B32">32</xref>]. This cleavage was not observed with a monovalent ligand, the receptor-associated protein RAP, suggesting the importance of multivalent, clustering-ligands in this process [<xref ref-type="bibr" rid="B9">9</xref>]. ApoE leads to release of extracellular domains and increased accumulation of C-terminal fragments of both VLDLR and ApoER2, but with less cleavage apparent for VLDLR than for ApoER2 [<xref ref-type="bibr" rid="B33">33</xref>].</p>
            <p>Proteolysis of VLDLR and ApoER2 can also be promoted by extracellular interactions of the receptors with the proprotein convertase PCSK9 [<xref ref-type="bibr" rid="B51">51</xref>]. PCSK9 was first associated with degradation of the LDL receptor [<xref ref-type="bibr" rid="B52">52</xref>], and is regulated by SREBP [<xref ref-type="bibr" rid="B53">53</xref>]. In addition, proteosomal degradation of VLDLR and ApoER2 can be induced by an E3 ubiquitin ligase (IDOL, Inducible Degrader of the LDL Receptor) [<xref ref-type="bibr" rid="B54">54</xref>]. IDOL is regulated under the LXR system [<xref ref-type="bibr" rid="B54">54</xref>], which is important for cellular cholesterol homeostasis. Thus, VLDLR and ApoER2 levels can be regulated in sterol-responsive ways, similar to the process for the LDL receptor.</p>
          </sec>
          <sec>
            <title>Intracellular</title>
            <p><underline>Disabled-1</underline> binds to VLDLR and ApoER2 intracellularly at NPxY motifs through its phosphotyrosine-binding (PTB) domain [<xref ref-type="bibr" rid="B8">8</xref>]. The PTB domain of Dab1 contains a hydrophobic groove and this structure creates the preference for the ApoER2 C-terminal helix [<xref ref-type="bibr" rid="B55">55</xref>]. Dab1 also binds Src and Fyn kinases, which are important in the downstream organizational effects of Reelin signaling [<xref ref-type="bibr" rid="B56">56</xref>]. The PTB structure has steric interference with phosphorylated tyrosines, explaining the preference for the NPxY motifs containing unphosphorylated tyrosines [<xref ref-type="bibr" rid="B55">55</xref>]. The presence of extracellular ligands such as Reelin increases the interaction of ApoER2 with Dab1 [<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B58">58</xref>]. Reelin-binding of VLDLR and ApoER2 result in similar and robust levels of Dab1 phosphorylation, and receptor-clustering mimics this effect [<xref ref-type="bibr" rid="B26">26</xref>]. Dab1 promotes surface localization of ApoER2 and its subsequent cleavage by &#x3B1;-secretase [<xref ref-type="bibr" rid="B58">58</xref>].</p>
            <p><underline>Disabled-2</underline> (Dab2), like its homolog Dab1, is a cytosolic adaptor protein. Dab2 is found at various locations in the embryonic mouse CNS throughout development, including the developing hindbrain, floor plate of the neural tube, choroid plexus, subcommissural organ, and pineal gland [<xref ref-type="bibr" rid="B59">59</xref>]. Like Dab1, Dab2 is thought to play a role in organization and cell positioning by signaling through LDL receptor family members [<xref ref-type="bibr" rid="B60">60</xref>], but it does not compensate for loss of Reelin signaling. Dab2 has been shown to regulate the MAPK pathway as well as Src activity [<xref ref-type="bibr" rid="B61">61</xref>]. Dab2 is also necessary for the internalization of ApoER2; the PTB domain of Dab2 interacts with the NPxY motif of ApoER2 and leads to internalization independent of exon 19 [<xref ref-type="bibr" rid="B62">62</xref>]. Dab2 does not bind VLDLR [<xref ref-type="bibr" rid="B60">60</xref>].</p>
            <p><underline>The Pafah1b complex</underline> of proteins consists of Lis1 (encoded by the <italic>Pafah1b1 </italic>gene) and two catalytic &#x3B1; subunits (encoded by <italic>Pafah1b2 </italic>and <italic>Pafah1b3</italic>) [<xref ref-type="bibr" rid="B63">63</xref>]. Heterozygous mutations of <italic>Pafah1b1 </italic>cause lissencephaly and a reduced number of cortical gyri, similar to the <italic>reeler </italic>phenotype [<xref ref-type="bibr" rid="B64">64</xref>]. In vitro, the &#x3B1;-subunits bind VLDLR at its NPVYL domain but not ApoER2, which has an NPVYR sequence [<xref ref-type="bibr" rid="B65">65</xref>]. Mouse models also support the conclusion that Pafah1b is functionally connected to VLDLR but not ApoER2 [<xref ref-type="bibr" rid="B65">65</xref>].</p>
            <p><underline>JIP-1 and JIP-2</underline> act as molecular scaffolds in the JNK-signaling pathway [<xref ref-type="bibr" rid="B66">66</xref>]. JIP-1 and JIP-2 were identified in a yeast two-hybrid assay as interactors with the alternatively-spliced exon 19 of ApoER2, and thus do not bind VLDLR, which lacks this domain [<xref ref-type="bibr" rid="B31">31</xref>]. The PID domain, rather than the SH3 domain, of JIP-2 was found to be responsible for the interaction with exon 19 [<xref ref-type="bibr" rid="B28">28</xref>]. The binding of JIPs and Dab1 to ApoER2 suggests that ApoER2 forms a scaffold for various interactors at the cell surface [<xref ref-type="bibr" rid="B28">28</xref>].</p>
            <p><underline>PSD-95</underline> is another adaptor protein that interacts preferentially with exon 19 of ApoER2 [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B67">67</xref>]. The first PDZ (PDZ1) domain of PSD-95 is responsible for the interaction with the intracellular exon 19 of ApoER2 [<xref ref-type="bibr" rid="B67">67</xref>]. PDZ2 of PSD-95 binds the NR2 subunit of NMDA receptors, possibly responsible for the complexes of ApoER2, NR2A, and PSD-95 formed in post-synaptic densities [<xref ref-type="bibr" rid="B29">29</xref>].</p>
            <p><underline>FE65</underline> has three functional domains: two PTB domains, and one WW domain [<xref ref-type="bibr" rid="B68">68</xref>]. FE65 binds to NPxY sequences in members of the LDL receptor family via its PTB1 domain [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B69">69</xref>]. FE65 interacts with ApoER2 [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B69">69</xref>] and VLDLR (GWR, unpublished data). The other domains of FE65 are important for linking apoE receptors to other proteins, such as the amyloid precursor protein via PTB2 [<xref ref-type="bibr" rid="B70">70</xref>], and to the cytoskeleton via the WW domain, affecting cell movement [<xref ref-type="bibr" rid="B71">71</xref>]. Knock-out of <italic>FE65 </italic>family members results in lissencephaly [<xref ref-type="bibr" rid="B72">72</xref>], as for several of the other proteins that interact with apoE receptors (see above).</p>
          </sec>
        </sec>
      </sec>
      <sec>
        <title>Unique functions of VLDLR and ApoER2</title>
        <p>One of the main differences between VLDLR and ApoER2 is that ApoER2 is restricted to the brain, testis, and placenta whereas VLDLR is expressed in tissues throughout the body. Both receptors are widely expressed in the brain, both during development and in the adult. Knockout mouse models of only <italic>ApoER2 </italic>or only <italic>VLDLR </italic>do not show the dramatic neuronal migration defects seen in the mice lacking both receptors, a phenocopy of <italic>Reelin </italic>and <italic>Dab1 </italic>knockouts [<xref ref-type="bibr" rid="B5">5</xref>]; this observation led to the hypothesis that the receptors have overlapping functions in the brain. However, several recent studies have begun to define distinct functions of VLDLR and ApoER2; we will discuss these distinctions in this section.</p>
        <sec>
          <title>Contributions to neuronal migration</title>
          <p>Reelin interacts extracellularly with VLDLR and ApoER2, promoting Dab1 phosphorylation intracellularly, and resulting in downstream effects that regulate proper migration of neurons during development [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B73">73</xref>]. As mentioned, double <italic>VLDLR</italic>/<italic>ApoER2 </italic>knock-outs show the full <italic>reeler </italic>phenotype, similar to animals lacking <italic>Reelin </italic>or <italic>Dab1 </italic>[<xref ref-type="bibr" rid="B74">74</xref>]. However, analyses of the single knock-out mouse models provide insight into different functions of ApoER2 and VLDLR. Both <italic>ApoER2 </italic>and <italic>VLDLR </italic>knock-outs have smaller, less foliated cerebella, less cortical lamination, and a splitting of the CA1 layer of the hippocampus [<xref ref-type="bibr" rid="B5">5</xref>]. However, the cortical and hippocampal defects were more pronounced in the <italic>ApoER2 </italic>knock-outs, and the cerebellar defect was more pronounced in the <italic>VLDLR </italic>knock-outs [<xref ref-type="bibr" rid="B5">5</xref>].</p>
          <p>In addition to these deficits, the <italic>VLDLR </italic>knock-out neurons demonstrated greater invasion of migrating cortical neurons into the marginal zone [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. Furthermore, fate mapping demonstrated that in <italic>ApoER2 </italic>knock-out mice, the late-born neurons fail to migrate properly in the cortex [<xref ref-type="bibr" rid="B23">23</xref>]. In <italic>VLDLR </italic>knockouts, the early-born cells ended up in an organized layer of the inner cortex (similar to wild-type animals), suggesting that VLDLR does not have a substantial effect on the limited migration of early-born neurons [<xref ref-type="bibr" rid="B23">23</xref>]. VLDLR is primarily expressed in the intermediate zone and the cortical plate adjacent to Reelin-expressing cells in the marginal zone [<xref ref-type="bibr" rid="B5">5</xref>]. These observations support a hypothesis that VLDLR mediates a neuronal "stop signal" [<xref ref-type="bibr" rid="B23">23</xref>]. In WT mice, ApoER2 receptors are most strongly expressed at E16.5 and E18.5, the stage when late-born neurons reach the superficial layers of the outer cortex. In the <italic>ApoER2 </italic>knock-out, the early-generated layers formed with minor deficits but late-generated layers were highly disrupted [<xref ref-type="bibr" rid="B23">23</xref>]. Antibodies against molecules of the radial glial scaffold revealed no abnormal arrangement of the radial glial cells. In <italic>ApoER2 </italic>knock-outs there is strong disruption of the radial alignment of the cortical neurons; this phenotype is not seen in the <italic>VLDLR</italic>-deficient cortex in which neurons are distributed radially [<xref ref-type="bibr" rid="B5">5</xref>]. Furthermore, neurons in <italic>ApoER2 </italic>knock-outs are packed into horizontal layers while the <italic>VLDLR </italic>knock-outs do not demonstrate discernable cortical lamina [<xref ref-type="bibr" rid="B5">5</xref>].</p>
          <p>Human mutations in the Reelin gene (<italic>RELN</italic>) gene cause neuronal migration defects, producing alterations in the architecture of the cortex and cerebellum [<xref ref-type="bibr" rid="B75">75</xref>]. The structural phenotype of lissencephaly, malformed hippocampus, and cerebellar hypoplasia is associated with a clinical phenotype of hypotonia, ataxia, and severe mental retardation [<xref ref-type="bibr" rid="B75">75</xref>]. Humans have also been identified with homozygous deletion of the <italic>VLDLR </italic>gene [<xref ref-type="bibr" rid="B76">76</xref>]. The <italic>VLDLR </italic>deletion causes a more mild cerebral gyral simplification, less cerebellar hypoplasia, and unremarkable changes to the hippocampus, compared with the <italic>RELN </italic>mutation [<xref ref-type="bibr" rid="B76">76</xref>]. Thus, the observations with mouse knock-out models support the findings in human genetic diseases.</p>
        </sec>
        <sec>
          <title>Pafah1b effects on neuronal migration via VLDLR</title>
          <p>Several of the proteins that interact with VLDLR and ApoER2 have been identified through mouse knock-out models that demonstrate effects on neuronal migration. The lissencephaly phenotype of <italic>Pafah1b1 </italic>heterozygous mutants sparked interest in exploring the relationship between the Pafah1b complex and the Reelin pathway, including the VLDLR and ApoER2 receptors [<xref ref-type="bibr" rid="B64">64</xref>]. The <italic>Pafah1b1</italic><sup>+/-</sup>;<italic>ApoER2</italic><sup>-/- </sup>double mutants had severe deficits in the forebrain, including inversion of cortical-lamina and hypercellularity of layer I similar to the <italic>reeler</italic>-like phenotype of an <italic>ApoER2</italic>;<italic>VLDLR </italic>double knock-out. However, <italic>Pafah1b1</italic><sup>+/-</sup>;<italic>VLDLR</italic><sup>-/- </sup>double mutants were mostly normal. The <italic>Pafah1b1</italic><sup>+/-</sup>;<italic>ApoER2</italic><sup>-/- </sup>mutants still underwent Dab1 phosphorylation when stimulated with Reelin (unlike in <italic>reeler </italic>mice), demonstrating that signaling was still intact (via VLDLR) but was not enough for proper cortical layer formation (requiring Lis1). The &#x3B1;-subunits serve as adapter-molecules by bringing Lis1 to VLDLR; one of the subunits (&#x3B1;2) binds to Dab1 [<xref ref-type="bibr" rid="B77">77</xref>]. The intact signaling suggests Lis1 is downstream of VLDLR and SRKs [<xref ref-type="bibr" rid="B65">65</xref>]. In humans, deletions and duplications of the <italic>PAFAH1B1 </italic>also result in neuronal migration defects, leading to a reduction in the number of cortical gyri [<xref ref-type="bibr" rid="B63">63</xref>,<xref ref-type="bibr" rid="B78">78</xref>,<xref ref-type="bibr" rid="B79">79</xref>]. Like the human <italic>VLDLR </italic>homozygous deletion [<xref ref-type="bibr" rid="B76">76</xref>], the <italic>PAFAH1B1 </italic>heterozygous deletion causes a somewhat milder phenotype than <italic>RELN </italic>mutations [<xref ref-type="bibr" rid="B75">75</xref>]. Thus, the Pafah1b complex mediates downstream effects of VLDLR on neuronal migration, but is not necessary for the function of ApoER2.</p>
        </sec>
        <sec>
          <title>Lipid-raft sorting</title>
          <p>Lipoprotein receptors are associated with clathrin-coated pits, indicative of a role in ligand endocytosis and degradation. However, ApoER2 is only found in caveolae-rich membrane fractions [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B80">80</xref>], distinguishing it from the non-lipid-raft VLDLR. Caveolae are a type of lipid raft primarily involved in signaling pathways [<xref ref-type="bibr" rid="B80">80</xref>]. Chimeric ApoER2 constructs containing only its cytoplasmic tail do not associate into rafts, suggesting it is the transmembrane or ectodomain involved in the sorting [<xref ref-type="bibr" rid="B26">26</xref>]. The transmembrane domain of ApoER2 has only 33% sequence identity compared with VLDLR (Figure <xref ref-type="fig" rid="F1">1</xref>); this low level of homology may be related to differential sorting of ApoER2 into lipid rafts.</p>
          <p>Thus, the different localization of ApoER2 and VLDLR may play a role in their different functions. Reelin is endocytosed via clathrin-coated vesicles and degraded by VLDLR much more efficiently than by ApoER2 [<xref ref-type="bibr" rid="B14">14</xref>]. In cell culture experiments, VLDLR facilitated degradation of more than 60% of bound Reelin after 12 minutes, and all of Reelin by 24 minutes. With ApoER2, after 24 minutes ~75% of Reelin remained associated with the cells [<xref ref-type="bibr" rid="B14">14</xref>]. Disruption of raft structures increased ApoER2-mediated Reelin endocytosis to the rate of VLDLR, indicating that ApoER2's localization in rafts results in reduced endocytosis. Reelin-binding resulted in a lysosomal (rather than proteosomal) degradation of ApoER2 but not of VLDLR, independent of raft-association [<xref ref-type="bibr" rid="B14">14</xref>]. However, ApoER2 bound by the non-clustering ligand RAP (receptor-associated protein) did not result in down regulation, suggesting that degradation is mediated by receptor clustering [<xref ref-type="bibr" rid="B14">14</xref>]. Thus, ApoER2 may be more important for the mediation of Reelin signaling in lipid rafts, and VLDLR may be more important for the intracellular degradation of Reelin.</p>
        </sec>
        <sec>
          <title>Neuronal signaling</title>
          <p>Activation of ApoE receptors directly promotes signal cascades involving the intracellular adaptor protein Dab1, increased activation of SFKs, and decreased activation of JNK [<xref ref-type="bibr" rid="B81">81</xref>]. Indirect activation of signaling involving calcium-mediated signal transduction pathways occurs through modification and subsequent increase in NMDAR conductance, which in turn can activate the extracellular signal-related kinases 1/2 (ERK1/2) [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B82">82</xref>]. It is unclear what the specific contributions are for each ApoE receptor or ligand; however, the use of the ligand Reelin has allowed for the identification of at least three specific pathways associated with ApoER2 and VLDLR activation. First, acute Reelin application to hippocampal slices results in NMDA receptor phosphorylation of both NR2A and NR2B subunits that is dependent on Src activation [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B67">67</xref>]. Second, chronic Reelin treatment of cultured hippocampal neurons shows a significant decrease in the number of silent synapses by increasing AMPA receptor insertion at synaptic terminals that is dependent on PI3K signaling [<xref ref-type="bibr" rid="B83">83</xref>]. Third, ApoE receptors affect the activation state on JNK through unstudied mechanisms [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B67">67</xref>]. JNK-interacting proteins JIP-1 and JIP-2 interact with exon 19 of ApoER2 [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B67">67</xref>], potentially affecting JNK signaling in many processes such as cell proliferation, morphogenesis and apoptosis [<xref ref-type="bibr" rid="B66">66</xref>]. In general, the interactions with exon 19 and consequent downstream signaling effects may explain some of the differences observed between ApoER2 and VLDLR. PSD-95 could act as a link between ApoER2 and NMDA receptors since the PDZ1 domain of PSD-95 binds ApoER2 and the PDZ2 domain of PSD-95 binds NMDA receptor subunits [<xref ref-type="bibr" rid="B67">67</xref>]. Thus, the formation of multimeric complexes of signaling proteins with ApoER2 may mediate specific signal transduction mechanisms.</p>
          <p>Analysis of <italic>ApoER2 </italic>and <italic>VLDLR </italic>knockout mice demonstrate that there are differential contributions of VLDLR and ApoER2 to hippocampal synaptic plasticity. Mice deficient for ApoER2 have a greater deficit in hippocampal area CA1 long-term potentiation (LTP) compared to VLDLR deficient mice, in particular when a theta-burst high frequency stimulation protocol is used [<xref ref-type="bibr" rid="B82">82</xref>]. The addition of Reelin can enhance LTP, but this requires the presence of both receptors [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B82">82</xref>]. This dual receptor dependency may reflect the necessity for the activation of signal transduction pathways from both receptors (described above) or the need for ApoER2/VLDLR clustering during Reelin binding. Nevertheless, current experimental evidence suggests that ApoER2 plays a signaling role independent of VLDLR. For example, the <italic>in vitro </italic>increase in LTP in the presence of Reelin requires interaction between ApoER2 and NMDA receptors through exon 19 of ApoER2 [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B67">67</xref>]. ApoER2 knockout mice or mice lacking exon 19 of ApoER2 show no Reelin-dependent changes in NMDARs or increase in LTP induction.</p>
        </sec>
      </sec>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>VLDLR and ApoER2 have homologous extracellular and intracellular domains and each is important for Reelin-mediated neuronal migration that depends on Dab1. Both undergo a series of proteolytic events that result in soluble forms of the receptors and intracellular domains, and that regulate active receptor levels. However, VLDLR and ApoER2 also interact with different ligands that define separate roles for these receptors in various signaling pathways. VLDLR has a broader tissue distribution and interacts specifically with the Pafah1b complex. ApoER2 is found in lipid rafts and interacts with PSD-95 and JIPs through a unique alternatively spliced sequence. These interactions affect signaling pathways regulated by intracellular calcium levels and JNK. As we continue to examine these receptors, we will better define their unique roles in neuronal migration and synaptic signaling.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>SSR did the literature review on ApoER2 and VLDLR comparisons, and TEC compiled and analyzed data. EJW and GWR suggested topics and edited the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgements</title>
      <p>Drs. Weeber and Rebeck are supported by NIH grants P01 AG030128 and R01 AG035379.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Beffert</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Stolt</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Functions of lipoprotein receptors in neurons</article-title>
          <source>J Lipid Res</source>
          <year>2004</year>
          <volume>45</volume>
          <fpage>403</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="pmid">14657206</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kim</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Iijima</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Goto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sakai</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ishii</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kondo</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Saeki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain</article-title>
          <source>J Biol Chem</source>
          <year>1996</year>
          <volume>271</volume>
          <fpage>8373</fpage>
          <lpage>8380</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.271.14.8373</pub-id>
          <pub-id pub-id-type="pmid">8626535</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tissir</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Goffinet</surname>
            <given-names>AM</given-names>
          </name>
          <article-title>Reelin and brain development</article-title>
          <source>Nat Rev Neurosci</source>
          <year>2003</year>
          <volume>4</volume>
          <fpage>496</fpage>
          <lpage>505</lpage>
          <pub-id pub-id-type="doi">10.1038/nrn1113</pub-id>
          <pub-id pub-id-type="pmid">12778121</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>D'Arcangelo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Miao</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Soares</surname>
            <given-names>HD</given-names>
          </name>
          <name>
            <surname>Morgan</surname>
            <given-names>JI</given-names>
          </name>
          <name>
            <surname>Curran</surname>
            <given-names>T</given-names>
          </name>
          <article-title>A protein related to extracellular matrix proteins deleted in the mouse mutant reeler</article-title>
          <source>Nature</source>
          <year>1995</year>
          <volume>374</volume>
          <fpage>719</fpage>
          <lpage>723</lpage>
          <pub-id pub-id-type="doi">10.1038/374719a0</pub-id>
          <pub-id pub-id-type="pmid">7715726</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Trommsdorff</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gotthardt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hiesberger</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Shelton</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Stockinger</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hammer</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Richardson</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2</article-title>
          <source>Cell</source>
          <year>1999</year>
          <volume>97</volume>
          <fpage>689</fpage>
          <lpage>701</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(00)80782-5</pub-id>
          <pub-id pub-id-type="pmid">10380922</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>D'Arcangelo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Homayouni</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Keshvara</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Rice</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Sheldon</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Curran</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Reelin is a ligand for lipoprotein receptors</article-title>
          <source>Neuron</source>
          <year>1999</year>
          <volume>24</volume>
          <fpage>471</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80860-0</pub-id>
          <pub-id pub-id-type="pmid">10571240</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Howell</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Hawkes</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Soriano</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>JA</given-names>
          </name>
          <article-title>Neuronal position in the developing brain is regulated by mouse disabled-1</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>389</volume>
          <fpage>733</fpage>
          <lpage>737</lpage>
          <pub-id pub-id-type="doi">10.1038/39607</pub-id>
          <pub-id pub-id-type="pmid">9338785</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Morimura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ogawa</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Relative importance of the tyrosine phosphorylation sites of Disabled-1 to the transmission of Reelin signaling</article-title>
          <source>Brain Res</source>
          <year>2009</year>
          <volume>1304</volume>
          <fpage>26</fpage>
          <lpage>37</lpage>
          <pub-id pub-id-type="pmid">19796633</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Strasser</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Fasching</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hauser</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mayer</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Bock</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Hiesberger</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Weeber</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Sweatt</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Pramatarova</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
          <article-title>Receptor clustering is involved in Reelin signaling</article-title>
          <source>Mol Cell Biol</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>1378</fpage>
          <lpage>1386</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.24.3.1378-1386.2004</pub-id>
          <pub-id pub-id-type="pmid">14729980</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Benhayon</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Magdaleno</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Curran</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of Disabled-1</article-title>
          <source>Brain Res Mol Brain Res</source>
          <year>2003</year>
          <volume>112</volume>
          <fpage>33</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">12670700</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rakic</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Caviness</surname>
            <given-names>VS</given-names>
            <suffix>Jr</suffix>
          </name>
          <article-title>Cortical development: view from neurological mutants two decades later</article-title>
          <source>Neuron</source>
          <year>1995</year>
          <volume>14</volume>
          <fpage>1101</fpage>
          <lpage>1104</lpage>
          <pub-id pub-id-type="doi">10.1016/0896-6273(95)90258-9</pub-id>
          <pub-id pub-id-type="pmid">7605626</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sheldon</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rice</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>D'Arcangelo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Yoneshima</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nakajima</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mikoshiba</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Howell</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Goldowitz</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Curran</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>389</volume>
          <fpage>730</fpage>
          <lpage>733</lpage>
          <pub-id pub-id-type="doi">10.1038/39601</pub-id>
          <pub-id pub-id-type="pmid">9338784</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kubo</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mikoshiba</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakajima</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Secreted Reelin molecules form homodimers</article-title>
          <source>Neurosci Res</source>
          <year>2002</year>
          <volume>43</volume>
          <fpage>381</fpage>
          <lpage>388</lpage>
          <pub-id pub-id-type="doi">10.1016/S0168-0102(02)00068-8</pub-id>
          <pub-id pub-id-type="pmid">12135781</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Duit</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mayer</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Blake</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Differential functions of ApoER2 and very low density lipoprotein receptor in Reelin signaling depend on differential sorting of the receptors</article-title>
          <source>J Biol Chem</source>
          <year>2010</year>
          <volume>285</volume>
          <fpage>4896</fpage>
          <lpage>4908</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M109.025973</pub-id>
          <pub-id pub-id-type="pmid">19948739</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bock</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Jossin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>May</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bergner</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Apolipoprotein E receptors are required for reelin-induced proteasomal degradation of the neuronal adaptor protein Disabled-1</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>33471</fpage>
          <lpage>33479</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M401770200</pub-id>
          <pub-id pub-id-type="pmid">15175346</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Strittmatter</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Roses</surname>
            <given-names>AD</given-names>
          </name>
          <article-title>Apolipoprotein E and Alzheimer's disease</article-title>
          <source>Annu Rev Neurosci</source>
          <year>1996</year>
          <volume>19</volume>
          <fpage>53</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.ne.19.030196.000413</pub-id>
          <pub-id pub-id-type="pmid">8833436</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Oka</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tzung</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Sullivan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lindsay</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Baldini</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Human very-low-density lipoprotein receptor complementary DNA and deduced amino acid sequence and localization of its gene (VLDLR) to chromosome band 9p24 by fluorescence in situ hybridization</article-title>
          <source>Genomics</source>
          <year>1994</year>
          <volume>20</volume>
          <fpage>298</fpage>
          <lpage>300</lpage>
          <pub-id pub-id-type="doi">10.1006/geno.1994.1171</pub-id>
          <pub-id pub-id-type="pmid">8020981</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Oka</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ishimura-Oka</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Sullivan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Krushkal</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>L</given-names>
          </name>
          <article-title>Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor</article-title>
          <source>Eur J Biochem</source>
          <year>1994</year>
          <volume>224</volume>
          <fpage>975</fpage>
          <lpage>982</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1432-1033.1994.00975.x</pub-id>
          <pub-id pub-id-type="pmid">7925422</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Christie</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Rebeck</surname>
            <given-names>GW</given-names>
          </name>
          <name>
            <surname>Strickland</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hyman</surname>
            <given-names>BT</given-names>
          </name>
          <article-title>Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>1996</year>
          <volume>55</volume>
          <fpage>491</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="doi">10.1097/00005072-199604000-00012</pub-id>
          <pub-id pub-id-type="pmid">8786409</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sakai</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tiebel</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Ljungberg</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Sullivan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Terashima</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kobayashi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Oka</surname>
            <given-names>K</given-names>
          </name>
          <article-title>A neuronal VLDLR variant lacking the third complement-type repeat exhibits high capacity binding of apoE containing lipoproteins</article-title>
          <source>Brain Res</source>
          <year>2009</year>
          <volume>1276</volume>
          <fpage>11</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="pmid">19393635</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Clatworthy</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Stockinger</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Christie</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hyman</surname>
            <given-names>BT</given-names>
          </name>
          <name>
            <surname>Rebeck</surname>
            <given-names>GW</given-names>
          </name>
          <article-title>Expression and alternate splicing of apolipoprotein E receptor 2 in brain</article-title>
          <source>Neuroscience</source>
          <year>1999</year>
          <volume>90</volume>
          <fpage>903</fpage>
          <lpage>911</lpage>
          <pub-id pub-id-type="doi">10.1016/S0306-4522(98)00489-8</pub-id>
          <pub-id pub-id-type="pmid">10218790</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Perez-Garcia</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Tissir</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Goffinet</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Meyer</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Reelin receptors in developing laminated brain structures of mouse and human</article-title>
          <source>Eur J Neurosci</source>
          <year>2004</year>
          <volume>20</volume>
          <fpage>2827</fpage>
          <lpage>2832</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1460-9568.2004.03733.x</pub-id>
          <pub-id pub-id-type="pmid">15548227</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hack</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Hellwig</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Junghans</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Brunne</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Bock</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Frotscher</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Divergent roles of ApoER2 and Vldlr in the migration of cortical neurons</article-title>
          <source>Development</source>
          <year>2007</year>
          <volume>134</volume>
          <fpage>3883</fpage>
          <lpage>3891</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.005447</pub-id>
          <pub-id pub-id-type="pmid">17913789</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nakamura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kumamaru</surname>
            <given-names>E</given-names>
          </name>
          <article-title>Significance of the variant and full-length forms of the very low density lipoprotein receptor in brain</article-title>
          <source>Brain Res</source>
          <year>2001</year>
          <volume>922</volume>
          <fpage>209</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.1016/S0006-8993(01)03170-5</pub-id>
          <pub-id pub-id-type="pmid">11743951</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Brandes</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kahr</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Stockinger</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hiesberger</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Alternative splicing in the ligand binding domain of mouse ApoE receptor-2 produces receptor variants binding reelin but not alpha 2-macroglobulin</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>22160</fpage>
          <lpage>22169</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M102662200</pub-id>
          <pub-id pub-id-type="pmid">11294845</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mayer</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Duit</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hauser</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Reconstitution of the Reelin signaling pathway in fibroblasts demonstrates that Dab1 phosphorylation is independent of receptor localization in lipid rafts</article-title>
          <source>Mol Cell Biol</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>19</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.26.1.19-27.2006</pub-id>
          <pub-id pub-id-type="pmid">16354676</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hibi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mizutani</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Baba</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hattori</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Splicing variations in the ligand-binding domain of ApoER2 results in functional differences in the binding properties to Reelin</article-title>
          <source>Neurosci Res</source>
          <year>2009</year>
          <volume>63</volume>
          <fpage>251</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neures.2008.12.009</pub-id>
          <pub-id pub-id-type="pmid">19167437</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Stockinger</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Brandes</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fasching</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hermann</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gotthardt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <article-title>The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>25625</fpage>
          <lpage>25632</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M004119200</pub-id>
          <pub-id pub-id-type="pmid">10827199</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Beffert</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Weeber</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Durudas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Masiulis</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Sweatt</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>WP</given-names>
          </name>
          <name>
            <surname>Adelmann</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Frotscher</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hammer</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2</article-title>
          <source>Neuron</source>
          <year>2005</year>
          <volume>47</volume>
          <fpage>567</fpage>
          <lpage>579</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2005.07.007</pub-id>
          <pub-id pub-id-type="pmid">16102539</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoe</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Rebeck</surname>
            <given-names>GW</given-names>
          </name>
          <article-title>Functional interactions of APP with the apoE receptor family</article-title>
          <source>J Neurochem</source>
          <year>2008</year>
          <volume>106</volume>
          <fpage>2263</fpage>
          <lpage>2271</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05517.x</pub-id>
          <pub-id pub-id-type="pmid">18554321</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gotthardt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Trommsdorff</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nevitt</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Shelton</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Richardson</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Stockinger</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>25616</fpage>
          <lpage>25624</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M000955200</pub-id>
          <pub-id pub-id-type="pmid">10827173</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>May</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bock</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>37386</fpage>
          <lpage>37392</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M305858200</pub-id>
          <pub-id pub-id-type="pmid">12871934</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoe</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Rebeck</surname>
            <given-names>GW</given-names>
          </name>
          <article-title>Regulation of ApoE receptor proteolysis by ligand binding</article-title>
          <source>Brain Res Mol Brain Res</source>
          <year>2005</year>
          <volume>137</volume>
          <fpage>31</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">15950758</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hiesberger</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Trommsdorff</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Howell</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Goffinet</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mumby</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation</article-title>
          <source>Neuron</source>
          <year>1999</year>
          <volume>24</volume>
          <fpage>481</fpage>
          <lpage>489</lpage>
          <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80861-2</pub-id>
          <pub-id pub-id-type="pmid">10571241</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nakano</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kohno</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hibi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kohno</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Baba</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mikoshiba</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nakajima</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hattori</surname>
            <given-names>M</given-names>
          </name>
          <article-title>The extremely conserved C-terminal region of Reelin is not necessary for secretion but is required for efficient activation of downstream signaling</article-title>
          <source>J Biol Chem</source>
          <year>2007</year>
          <volume>282</volume>
          <fpage>20544</fpage>
          <lpage>20552</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M702300200</pub-id>
          <pub-id pub-id-type="pmid">17504759</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yasui</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Nogi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Takagi</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Structural basis for specific recognition of reelin by its receptors</article-title>
          <source>Structure</source>
          <year>2010</year>
          <volume>18</volume>
          <fpage>320</fpage>
          <lpage>331</lpage>
          <pub-id pub-id-type="doi">10.1016/j.str.2010.01.010</pub-id>
          <pub-id pub-id-type="pmid">20223215</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lambert de Rouvroit</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bernier</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Royaux</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>de Bergeyck</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Goffinet</surname>
            <given-names>AM</given-names>
          </name>
          <article-title>Evolutionarily conserved, alternative splicing of reelin during brain development</article-title>
          <source>Exp Neurol</source>
          <year>1999</year>
          <volume>156</volume>
          <fpage>229</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="doi">10.1006/exnr.1999.7019</pub-id>
          <pub-id pub-id-type="pmid">10328932</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Jossin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ignatova</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hiesberger</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lambert de Rouvroit</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Goffinet</surname>
            <given-names>AM</given-names>
          </name>
          <article-title>The central fragment of Reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development</article-title>
          <source>J Neurosci</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>514</fpage>
          <lpage>521</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3408-03.2004</pub-id>
          <pub-id pub-id-type="pmid">14724251</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ruiz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kouiavskaia</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Migliorini</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Saenko</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Gorlatova</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lawrence</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hyman</surname>
            <given-names>BT</given-names>
          </name>
          <name>
            <surname>Weisgraber</surname>
            <given-names>KH</given-names>
          </name>
          <name>
            <surname>Strickland</surname>
            <given-names>DK</given-names>
          </name>
          <article-title>The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor</article-title>
          <source>J Lipid Res</source>
          <year>2005</year>
          <volume>46</volume>
          <fpage>1721</fpage>
          <lpage>1731</lpage>
          <pub-id pub-id-type="doi">10.1194/jlr.M500114-JLR200</pub-id>
          <pub-id pub-id-type="pmid">15863833</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Durakoglugil</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Xian</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <article-title>ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2010</year>
          <volume>107</volume>
          <fpage>12011</fpage>
          <lpage>12016</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0914984107</pub-id>
          <pub-id pub-id-type="pmid">20547867</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Adams</surname>
            <given-names>JC</given-names>
          </name>
          <article-title>Thrombospondins: multifunctional regulators of cell interactions</article-title>
          <source>Annu Rev Cell Dev Biol</source>
          <year>2001</year>
          <volume>17</volume>
          <fpage>25</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.cellbio.17.1.25</pub-id>
          <pub-id pub-id-type="pmid">11687483</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Christopherson</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Ullian</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Stokes</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Mullowney</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Hell</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Agah</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lawler</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mosher</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Bornstein</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Barres</surname>
            <given-names>BA</given-names>
          </name>
          <article-title>Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis</article-title>
          <source>Cell</source>
          <year>2005</year>
          <volume>120</volume>
          <fpage>421</fpage>
          <lpage>433</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2004.12.020</pub-id>
          <pub-id pub-id-type="pmid">15707899</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Blake</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Strasser</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Andrade</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Duit</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hofbauer</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Thrombospondin-1 binds to ApoER2 and VLDL receptor and functions in postnatal neuronal migration</article-title>
          <source>Embo J</source>
          <year>2008</year>
          <volume>27</volume>
          <fpage>3069</fpage>
          <lpage>3080</lpage>
          <pub-id pub-id-type="doi">10.1038/emboj.2008.223</pub-id>
          <pub-id pub-id-type="pmid">18946489</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Klar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Baldassare</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jessell</surname>
            <given-names>TM</given-names>
          </name>
          <article-title>F-spondin: a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension</article-title>
          <source>Cell</source>
          <year>1992</year>
          <volume>69</volume>
          <fpage>95</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.1016/0092-8674(92)90121-R</pub-id>
          <pub-id pub-id-type="pmid">1555244</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoe</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Wessner</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Beffert</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Becker</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Matsuoka</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Rebeck</surname>
            <given-names>GW</given-names>
          </name>
          <article-title>F-spondin interaction with the apolipoprotein E receptor ApoEr2 affects processing of amyloid precursor protein</article-title>
          <source>Mol Cell Biol</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>9259</fpage>
          <lpage>9268</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.25.21.9259-9268.2005</pub-id>
          <pub-id pub-id-type="pmid">16227578</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Andrade</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Komnenovic</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Blake</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Jossin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Howell</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Goffinet</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <article-title>ApoER2/VLDL receptor and Dab1 in the rostral migratory stream function in postnatal neuronal migration independently of Reelin</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>8508</fpage>
          <lpage>8513</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0611391104</pub-id>
          <pub-id pub-id-type="pmid">17494763</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Peterziel</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sackmann</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Strelau</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kuhn</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>Lichtenthaler</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>Marom</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Klar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Unsicker</surname>
            <given-names>K</given-names>
          </name>
          <article-title>F-spondin regulates neuronal survival through activation of disabled-1 in the chicken ciliary ganglion</article-title>
          <source>Mol Cell Neurosci</source>
          <year>2011</year>
          <volume>46</volume>
          <fpage>483</fpage>
          <lpage>497</lpage>
          <pub-id pub-id-type="doi">10.1016/j.mcn.2010.12.001</pub-id>
          <pub-id pub-id-type="pmid">21145970</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Olson</surname>
            <given-names>GE</given-names>
          </name>
          <name>
            <surname>Winfrey</surname>
            <given-names>VP</given-names>
          </name>
          <name>
            <surname>Nagdas</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Burk</surname>
            <given-names>RF</given-names>
          </name>
          <article-title>Apolipoprotein E receptor-2 (ApoER2) mediates selenium uptake from selenoprotein P by the mouse testis</article-title>
          <source>J Biol Chem</source>
          <year>2007</year>
          <volume>282</volume>
          <fpage>12290</fpage>
          <lpage>12297</lpage>
          <pub-id pub-id-type="pmid">17314095</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Burk</surname>
            <given-names>RF</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Olson</surname>
            <given-names>GE</given-names>
          </name>
          <name>
            <surname>Weeber</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Motley</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Winfrey</surname>
            <given-names>VP</given-names>
          </name>
          <name>
            <surname>Austin</surname>
            <given-names>LM</given-names>
          </name>
          <article-title>Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed</article-title>
          <source>J Neurosci</source>
          <year>2007</year>
          <volume>27</volume>
          <fpage>6207</fpage>
          <lpage>6211</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1153-07.2007</pub-id>
          <pub-id pub-id-type="pmid">17553992</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Valentine</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Abel</surname>
            <given-names>TW</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Austin</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Burk</surname>
            <given-names>RF</given-names>
          </name>
          <article-title>Neurodegeneration in mice resulting from loss of functional selenoprotein P or its receptor apolipoprotein E receptor 2</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>2008</year>
          <volume>67</volume>
          <fpage>68</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="doi">10.1097/NEN.0b013e318160f347</pub-id>
          <pub-id pub-id-type="pmid">18172410</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Poirier</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mayer</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Benjannet</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bergeron</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Marcinkiewicz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nassoury</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Mayer</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nimpf</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Prat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Seidah</surname>
            <given-names>NG</given-names>
          </name>
          <article-title>The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2</article-title>
          <source>J Biol Chem</source>
          <year>2008</year>
          <volume>283</volume>
          <fpage>2363</fpage>
          <lpage>2372</lpage>
          <pub-id pub-id-type="pmid">18039658</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Maxwell</surname>
            <given-names>KN</given-names>
          </name>
          <name>
            <surname>Breslow</surname>
            <given-names>JL</given-names>
          </name>
          <article-title>Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>7100</fpage>
          <lpage>7105</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0402133101</pub-id>
          <pub-id pub-id-type="pmid">15118091</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Park</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Moon</surname>
            <given-names>YA</given-names>
          </name>
          <name>
            <surname>Horton</surname>
            <given-names>JD</given-names>
          </name>
          <article-title>Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver</article-title>
          <source>J Biol Chem</source>
          <year>2004</year>
          <volume>279</volume>
          <fpage>50630</fpage>
          <lpage>50638</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M410077200</pub-id>
          <pub-id pub-id-type="pmid">15385538</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hong</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Duit</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jalonen</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Out</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Scheer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sorrentino</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Boyadjian</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Rodenburg</surname>
            <given-names>KW</given-names>
          </name>
          <name>
            <surname>Foley</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Korhonen</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
          <article-title>The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2</article-title>
          <source>J Biol Chem</source>
          <year>2010</year>
          <volume>285</volume>
          <fpage>19720</fpage>
          <lpage>19726</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M110.123729</pub-id>
          <pub-id pub-id-type="pmid">20427281</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Stolt</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Jeon</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Eck</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Blacklow</surname>
            <given-names>SC</given-names>
          </name>
          <article-title>Origins of peptide selectivity and phosphoinositide binding revealed by structures of disabled-1 PTB domain complexes</article-title>
          <source>Structure</source>
          <year>2003</year>
          <volume>11</volume>
          <fpage>569</fpage>
          <lpage>579</lpage>
          <pub-id pub-id-type="doi">10.1016/S0969-2126(03)00068-6</pub-id>
          <pub-id pub-id-type="pmid">12737822</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B56">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Howell</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Gertler</surname>
            <given-names>FB</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>JA</given-names>
          </name>
          <article-title>Mouse disabled (mDab1): a Src binding protein implicated in neuronal development</article-title>
          <source>Embo J</source>
          <year>1997</year>
          <volume>16</volume>
          <fpage>121</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="doi">10.1093/emboj/16.1.121</pub-id>
          <pub-id pub-id-type="pmid">9009273</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B57">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Morimura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hattori</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ogawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mikoshiba</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Disabled1 regulates the intracellular trafficking of reelin receptors</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>16901</fpage>
          <lpage>16908</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M409048200</pub-id>
          <pub-id pub-id-type="pmid">15718228</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B58">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoe</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Tran</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Matsuoka</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Howell</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Rebeck</surname>
            <given-names>GW</given-names>
          </name>
          <article-title>DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing</article-title>
          <source>J Biol Chem</source>
          <year>2006</year>
          <volume>281</volume>
          <fpage>35176</fpage>
          <lpage>35185</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M602162200</pub-id>
          <pub-id pub-id-type="pmid">16951405</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B59">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cheung</surname>
            <given-names>KK</given-names>
          </name>
          <name>
            <surname>Mok</surname>
            <given-names>SC</given-names>
          </name>
          <name>
            <surname>Rezaie</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>WY</given-names>
          </name>
          <article-title>Dynamic expression of Dab2 in the mouse embryonic central nervous system</article-title>
          <source>BMC Dev Biol</source>
          <year>2008</year>
          <volume>8</volume>
          <fpage>76</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-213X-8-76</pub-id>
          <pub-id pub-id-type="pmid">18680569</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B60">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yang</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>ER</given-names>
          </name>
          <name>
            <surname>Roland</surname>
            <given-names>IH</given-names>
          </name>
          <name>
            <surname>Sheng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>WD</given-names>
          </name>
          <name>
            <surname>Hamilton</surname>
            <given-names>TC</given-names>
          </name>
          <name>
            <surname>Lambeth</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>XX</given-names>
          </name>
          <article-title>Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis</article-title>
          <source>Dev Biol</source>
          <year>2002</year>
          <volume>251</volume>
          <fpage>27</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1006/dbio.2002.0810</pub-id>
          <pub-id pub-id-type="pmid">12413896</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B61">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zhou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Scholes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hsieh</surname>
            <given-names>JT</given-names>
          </name>
          <article-title>Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>6936</fpage>
          <lpage>6941</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M210628200</pub-id>
          <pub-id pub-id-type="pmid">12473651</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B62">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cuitino</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Matute</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Retamal</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Inestrosa</surname>
            <given-names>NC</given-names>
          </name>
          <name>
            <surname>Marzolo</surname>
            <given-names>MP</given-names>
          </name>
          <article-title>ApoER2 is endocytosed by a clathrin-mediated process involving the adaptor protein Dab2 independent of its Rafts' association</article-title>
          <source>Traffic</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>820</fpage>
          <lpage>838</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0854.2005.00320.x</pub-id>
          <pub-id pub-id-type="pmid">16101684</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B63">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Reiner</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Carrozzo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wehnert</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Faustinella</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Dobyns</surname>
            <given-names>WB</given-names>
          </name>
          <name>
            <surname>Caskey</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Ledbetter</surname>
            <given-names>DH</given-names>
          </name>
          <article-title>Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats</article-title>
          <source>Nature</source>
          <year>1993</year>
          <volume>364</volume>
          <fpage>717</fpage>
          <lpage>721</lpage>
          <pub-id pub-id-type="doi">10.1038/364717a0</pub-id>
          <pub-id pub-id-type="pmid">8355785</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B64">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Assadi</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Beffert</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>McNeil</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Renfro</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Niu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Quattrocchi</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Antalffy</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Sheldon</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Armstrong</surname>
            <given-names>DD</given-names>
          </name>
          <etal/>
          <article-title>Interaction of reelin signaling and Lis1 in brain development</article-title>
          <source>Nat Genet</source>
          <year>2003</year>
          <volume>35</volume>
          <fpage>270</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1257</pub-id>
          <pub-id pub-id-type="pmid">14578885</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B65">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zhang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Assadi</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>McNeil</surname>
            <given-names>RS</given-names>
          </name>
          <name>
            <surname>Beffert</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Wynshaw-Boris</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>D'Arcangelo</surname>
            <given-names>G</given-names>
          </name>
          <article-title>The Pafah1b complex interacts with the reelin receptor VLDLR</article-title>
          <source>PLoS One</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>e252</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0000252</pub-id>
          <pub-id pub-id-type="pmid">17330141</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B66">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Whitmarsh</surname>
            <given-names>AJ</given-names>
          </name>
          <article-title>The JIP family of MAPK scaffold proteins</article-title>
          <source>Biochem Soc Trans</source>
          <year>2006</year>
          <volume>34</volume>
          <fpage>828</fpage>
          <lpage>832</lpage>
          <pub-id pub-id-type="pmid">17052208</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B67">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoe</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Pocivavsek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chakraborty</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Vicini</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ehlers</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Rebeck</surname>
            <given-names>GW</given-names>
          </name>
          <article-title>Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor</article-title>
          <source>J Biol Chem</source>
          <year>2006</year>
          <volume>281</volume>
          <fpage>3425</fpage>
          <lpage>3431</lpage>
          <pub-id pub-id-type="pmid">16332682</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B68">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Russo</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Faraonio</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Minopoli</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>De Candia</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>De Renzis</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zambrano</surname>
            <given-names>N</given-names>
          </name>
          <article-title>Fe65 and the protein network centered around the cytosolic domain of the Alzheimer's beta-amyloid precursor protein</article-title>
          <source>FEBS Lett</source>
          <year>1998</year>
          <volume>434</volume>
          <fpage>1</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-5793(98)00941-7</pub-id>
          <pub-id pub-id-type="pmid">9738440</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B69">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoe</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Magill</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Guenette</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Vicini</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rebeck</surname>
            <given-names>GW</given-names>
          </name>
          <article-title>FE65 interaction with the ApoE receptor ApoEr2</article-title>
          <source>J Biol Chem</source>
          <year>2006</year>
          <volume>281</volume>
          <fpage>24521</fpage>
          <lpage>24530</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M600728200</pub-id>
          <pub-id pub-id-type="pmid">16638748</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B70">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Guenette</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jondro</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Tanzi</surname>
            <given-names>RE</given-names>
          </name>
          <article-title>Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1996</year>
          <volume>93</volume>
          <fpage>10832</fpage>
          <lpage>10837</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.93.20.10832</pub-id>
          <pub-id pub-id-type="pmid">8855266</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B71">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sabo</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Ikin</surname>
            <given-names>AF</given-names>
          </name>
          <name>
            <surname>Buxbaum</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Greengard</surname>
            <given-names>P</given-names>
          </name>
          <article-title>The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement</article-title>
          <source>J Cell Biol</source>
          <year>2001</year>
          <volume>153</volume>
          <fpage>1403</fpage>
          <lpage>1414</lpage>
          <pub-id pub-id-type="doi">10.1083/jcb.153.7.1403</pub-id>
          <pub-id pub-id-type="pmid">11425871</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B72">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Guenette</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hiesberger</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Richardson</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Eckman</surname>
            <given-names>CB</given-names>
          </name>
          <name>
            <surname>Eckman</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Hammer</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development</article-title>
          <source>Embo J</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>420</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.emboj.7600926</pub-id>
          <pub-id pub-id-type="pmid">16407979</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B73">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Howell</surname>
            <given-names>BW</given-names>
          </name>
          <name>
            <surname>Herrick</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Hildebrand</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>JA</given-names>
          </name>
          <article-title>Dab1 tyrosine phosphorylation sites relay positional signals during mouse brain development</article-title>
          <source>Curr Biol</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>877</fpage>
          <lpage>885</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-9822(00)00608-4</pub-id>
          <pub-id pub-id-type="pmid">10959835</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B74">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bock</surname>
            <given-names>HH</given-names>
          </name>
          <article-title>Lipoprotein receptors in the nervous system</article-title>
          <source>Annu Rev Biochem</source>
          <year>2002</year>
          <volume>71</volume>
          <fpage>405</fpage>
          <lpage>434</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.biochem.71.110601.135342</pub-id>
          <pub-id pub-id-type="pmid">12045102</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B75">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hong</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Shugart</surname>
            <given-names>YY</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Shahwan</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Hourihane</surname>
            <given-names>JO</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>ND</given-names>
          </name>
          <name>
            <surname>Walsh</surname>
            <given-names>CA</given-names>
          </name>
          <article-title>Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations</article-title>
          <source>Nat Genet</source>
          <year>2000</year>
          <volume>26</volume>
          <fpage>93</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="doi">10.1038/79246</pub-id>
          <pub-id pub-id-type="pmid">10973257</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B76">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Boycott</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Flavelle</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bureau</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Glass</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Fujiwara</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Wirrell</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Davey</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Chudley</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>McLeod</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Parboosingh</surname>
            <given-names>JS</given-names>
          </name>
          <article-title>Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification</article-title>
          <source>Am J Hum Genet</source>
          <year>2005</year>
          <volume>77</volume>
          <fpage>477</fpage>
          <lpage>483</lpage>
          <pub-id pub-id-type="doi">10.1086/444400</pub-id>
          <pub-id pub-id-type="pmid">16080122</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B77">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zhang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Assadi</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Roceri</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>GD</given-names>
          </name>
          <name>
            <surname>D'Arcangelo</surname>
            <given-names>G</given-names>
          </name>
          <article-title>Differential interaction of the Pafah1b alpha subunits with the Reelin transducer Dab1</article-title>
          <source>Brain Res</source>
          <year>2009</year>
          <volume>1267</volume>
          <fpage>1</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">19272360</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B78">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hattori</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Adachi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tsujimoto</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Arai</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase [corrected]</article-title>
          <source>Nature</source>
          <year>1994</year>
          <volume>370</volume>
          <fpage>216</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="doi">10.1038/370216a0</pub-id>
          <pub-id pub-id-type="pmid">8028668</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B79">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bi</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Sapir</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Shchelochkov</surname>
            <given-names>OA</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Withers</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>JV</given-names>
          </name>
          <name>
            <surname>Levy</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Shinder</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Peiffer</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Gunderson</surname>
            <given-names>KL</given-names>
          </name>
          <etal/>
          <article-title>Increased LIS1 expression affects human and mouse brain development</article-title>
          <source>Nat Genet</source>
          <year>2009</year>
          <volume>41</volume>
          <fpage>168</fpage>
          <lpage>177</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.302</pub-id>
          <pub-id pub-id-type="pmid">19136950</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B80">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Riddell</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>XM</given-names>
          </name>
          <name>
            <surname>Stannard</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Soutar</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Owen</surname>
            <given-names>JS</given-names>
          </name>
          <article-title>Localization of apolipoprotein E receptor 2 to caveolae in the plasma membrane</article-title>
          <source>J Lipid Res</source>
          <year>2001</year>
          <volume>42</volume>
          <fpage>998</fpage>
          <lpage>1002</lpage>
          <pub-id pub-id-type="pmid">11369809</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B81">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoe</surname>
            <given-names>HS</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Rebeck</surname>
            <given-names>GW</given-names>
          </name>
          <article-title>Multiple pathways of apolipoprotein E signaling in primary neurons</article-title>
          <source>J Neurochem</source>
          <year>2005</year>
          <volume>93</volume>
          <fpage>145</fpage>
          <lpage>155</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.03007.x</pub-id>
          <pub-id pub-id-type="pmid">15773914</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B82">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Weeber</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Beffert</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Christian</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Forster</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sweatt</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Herz</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>39944</fpage>
          <lpage>39952</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M205147200</pub-id>
          <pub-id pub-id-type="pmid">12167620</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B83">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Qiu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Weeber</surname>
            <given-names>EJ</given-names>
          </name>
          <article-title>Reelin signaling facilitates maturation of CA1 glutamatergic synapses</article-title>
          <source>J Neurophysiol</source>
          <year>2007</year>
          <volume>97</volume>
          <fpage>2312</fpage>
          <lpage>2321</lpage>
          <pub-id pub-id-type="doi">10.1152/jn.00869.2006</pub-id>
          <pub-id pub-id-type="pmid">17229826</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
